FIELD: medicine.
SUBSTANCE: there are presented: a method of treating a disorder associated with the exposure to an alkylating agent specified in a group: sulphur mustard, nitrogen mustard, chlorine gas, 2-chlor-ethylethylsulphide and phosgene gas by introducing an effective amount of tetrakis-N,N-diethylimidazolium porphyrine or a pharmaceutically acceptable salt, particularly AEOL-10150, and a respective method for protection of an individual against toxic effects related to the exposure to the above alkylating agents. The porphirin AEOL-10150 analogue, a free radical acceptor MnTbap keeps the cell viability unchanged in the similar environment.
EFFECT: what is shown is achieving the declared applications: prevention of the organ disorders, and organ recovery following the exposure to sulphur mustard.
15 cl, 15 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METALLOPORPHYRIN TREATMENT OF NEUROLOGICAL DISEASES | 2012 |
|
RU2623207C2 |
| CFTR REGULATORS AND METHODS FOR USE THEREOF | 2016 |
|
RU2742934C2 |
| CFTR REGULATORS AND THEIR APPLICATION METHODS | 2016 |
|
RU2749834C2 |
| CFTR REGULATORS AND METHODS OF USING | 2016 |
|
RU2730855C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2513636C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2537549C2 |
| AMYLOID-BINDING AGENTS | 2010 |
|
RU2517174C2 |
| NOVEL COMPOUNDS AND COMPOSITIONS FOR INHIBITION OF FASN | 2014 |
|
RU2686323C2 |
| CERTAIN CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2014 |
|
RU2716703C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS | 2009 |
|
RU2569303C2 |
